Interleukin 6 is a better predictor of 5-year cardiovascular mortality than high-sensitivity C-reactive protein in hemodialysis patients using reused low-flux dialyzers
| Autor: | Le Viet Thang, Nguyen Huu Dung, Do Manh Ha, Truong Quy Kien, Nguyen Thi Dung, Diem T. Van, Nguyen Trung Kien, Vu Xuan Nghia, Nguyen Minh Tuan, Dao Bui Quy Quyen, Nguyen Van Duc, Pham Quoc Toan, Nguyen Thu Ha, Nguyen Duc Loc |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Adult
Male Nephrology medicine.medical_specialty Time Factors Urology medicine.medical_treatment 030232 urology & nephrology Serum albumin 030204 cardiovascular system & hematology Gastroenterology 03 medical and health sciences 0302 clinical medicine Predictive Value of Tests Renal Dialysis Internal medicine Equipment Reuse medicine Humans Interleukin 6 Dialysis Cardiovascular mortality biology Interleukin-6 business.industry C-reactive protein Middle Aged C-Reactive Protein Cardiovascular Diseases biology.protein Female Hemoglobin Hemodialysis business |
| Zdroj: | International Urology and Nephrology. 52:1135-1142 |
| ISSN: | 1573-2584 0301-1623 |
| Popis: | In this study, we focused on the role of elevated serum interleukin 6 (IL-6) concentration in predicting 5-year cardiovascular mortality in hemodialysis patients using low-flux dialyzer reuse. We measured serum IL-6 concentrations in 236 hemodialysis patients (138 males and 98 females) to predict 5-year cardiovascular mortality. We assessed the baseline demographics of all patients who had a mean age of 44 years and a median hemodialysis duration of 38.5 months. We divided all patients into two equal groups based on the serum IL-6 concentration: G1 (n = 118) with serum IL-6 concentration |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full text from SpringerLink